Cabot Corporation (NYSE:CBT - Get Free Report) CEO Sean Keohane sold 134,895 shares of Cabot stock in a transaction on Friday, August 28th. The stock was sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the transaction, the chief executive officer directly owned 404,134 shares of the company's stock, valued at $34,351,390. The trade was a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Cabot Trading Down 1.1%
CBT stock opened at $82.72 on Tuesday. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $94.53. The stock has a market capitalization of $4.27 billion, a price-to-earnings ratio of 23.30, a price-to-earnings-growth ratio of 10.98 and a beta of 0.84. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The firm's fifty day simple moving average is $87.46 and its two-hundred day simple moving average is $81.29.
Cabot (NYSE:CBT - Get Free Report) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The firm had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. During the same quarter last year, the business earned $1.90 EPS. The business's revenue was up 6.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, analysts anticipate that Cabot Corporation will post 6.35 earnings per share for the current year.
Cabot Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be paid a $0.4725 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 annualized dividend and a yield of 2.3%. Cabot's dividend payout ratio (DPR) is presently 53.24%.
Institutional Trading of Cabot
Institutional investors and hedge funds have recently made changes to their positions in the company. Rothschild Investment LLC lifted its stake in Cabot by 170.4% in the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company's stock worth $27,000 after acquiring an additional 259 shares during the period. Northwestern Mutual Wealth Management Co. purchased a new position in Cabot during the 2nd quarter valued at about $33,000. Global Retirement Partners LLC increased its position in Cabot by 1,606.9% during the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company's stock valued at $33,000 after purchasing an additional 466 shares during the period. Geneos Wealth Management Inc. raised its holdings in shares of Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company's stock valued at $38,000 after purchasing an additional 364 shares in the last quarter. Finally, Danske Bank A S bought a new stake in shares of Cabot in the 3rd quarter valued at about $38,000. 93.18% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on CBT shares. UBS Group cut their target price on Cabot from $97.00 to $92.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 5th. Mizuho raised their price target on Cabot from $80.00 to $90.00 and gave the stock a "neutral" rating in a research note on Thursday, June 25th. Wall Street Zen upgraded Cabot from a "hold" rating to a "buy" rating in a report on Sunday, August 9th. Truist Financial set a $100.00 price objective on Cabot in a research report on Wednesday, August 5th. Finally, JPMorgan Chase & Co. increased their target price on Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a research note on Friday, August 7th. Two equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $89.00.
Read Our Latest Report on CBT
About Cabot
(
Get Free Report)
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
